• About
  • Subscribe
  • Advertise
  • Contact
Monday, November 10, 2025
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home News

Visual implant developed with ‘electrodes the size of a single neuron’

by Staff Writer
May 13, 2024
in International, News, Research
Reading Time: 2 mins read
A A
The devices were implanted in the primary visual cortex of mice. Image: Sebastian Kaulitzki/stock.adobe.com.

The devices were implanted in the primary visual cortex of mice. Image: Sebastian Kaulitzki/stock.adobe.com.

Share on FacebookShare on Twitter

Researchers have developed highly flexible and durable electrodes the size of a single neuron which could pave the way for the next generation of visual implants.

In a study, published in Advanced Healthcare Materials, the international research team said the electrodes exhibited “remarkable” stability when several billions of electrical pulses are applied in vitro.

The devices were implanted in the primary visual cortex of mice, which were trained to detect electrical microstimulation. The mice were able to detect impulses at two to 20 microamperes, which is far below the maximal currents that the electrodes can withstand.

“The long-term functionality of the devices in vivo is excellent, with stable performance for up to more than a year and little damage to the brain tissue,” the study authors said.

“These results demonstrate the potential of thin floating electrodes for the long-term restoration of lost sensory functions.”

A key challenge with visual prosthetics is deterioration of the interface. This can be caused by bio-instability of the materials, electrochemical degradation of electrodes and the brain’s foreign body response to the implant.

The implant developed by the researchers measured 40 micrometres wide and 10 micrometres thick and were made from ultra-flexible, polyimide shanks that allowed them to withstand deterioration and not damage brain tissue.

The researchers applied billions of electrical pulses to the electrodes – mimicking years of continuous use – which showed little to no degradation in performance. Moreover, the implants remained stable for up to a year after implantation due to its mild foreign body response.

“We conclude that thin film polymers with small electrodes provide a promising avenue for sensory prostheses that aim to activate neurons at a high spatial resolution over extended time periods,” the study authors said.

They said substantial work is still needed before translating this technology into medical devices that can be safely used in blind people.

“For example, there is a need to develop methods to safely implant and interconnect large numbers of electrodes in the visual brain; while, covering the entire visual field representation.”

“Nevertheless, the present work represents an important step in this direction by demonstrating a long-lasting, stable, and high-resolution interface with the visual brain.”

More reading

FDA breakthrough for Australian bionic eye

Human trials on the horizon for Sydney team’s bionic eye

Inherited retinal diseases cost Australia at least $781 million a year

Related Posts

The Frey Auto Perimeter AP-600. Image: BOC Instruments.

BOC Instruments now exclusive supplier of Frey products

by Staff Writer
November 10, 2025

Ophthalmic equipment supplier BOC Instruments is now the exclusive Australian distributor for the complete range of Frey products. The company...

The event will feature a full-day program of research presentations, discussions, and networking opportunities. Image: The Royal Victorian Eye and Ear Hospital.

Collaborative ocular oncology research day to unite experts across ANZ

by Staff Writer
November 7, 2025

Melbourne will host the first ocular oncology research day, bringing together leading experts from Australia, New Zealand, and the US...

Optometry Australia is discussing a change to its structure. Image: Starmarpro/stock.adobe.com.

Optometry Australia discussing restructure

by Staff Writer
November 6, 2025

Optometry Australia (OA) is discussing a restructure of the organisation. In a release on its website, it said OA and...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited